Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Atenolol on Pro-thrombotic State in Hypertension
NCT00171756Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Change from baseline in a clinical laboratory measurement of a blood clotting factor at 12 weeks. Started Jun 2004; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00171756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171756.